1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
Delayed London Stock Exchange  -  05/17 11:35:08 am EDT
10488.00 GBX   +0.21%
08:04aWhat you need to know about the coronavirus right now
RE
05:01aASTRAZENECA : Deutsche Bank keeps its Buy rating
MD
04:53aAstraZeneca Obtains Exclusive Global License To Develop Antibodies Against COVID-19
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

ASTRAZENECA : JP Morgan reiterates its Buy rating

01/19/2022 | 09:29am EDT

In a research note published by James Gordon, JP Morgan advises its customers to buy the stock. The target price continues to be set at GBX 10000.


ę MarketScreener with dpa-AFX Analyser 2022
All news about ASTRAZENECA PLC
08:04aWhat you need to know about the coronavirus right now
RE
05:01aASTRAZENECA : Deutsche Bank keeps its Buy rating
MD
04:53aAstraZeneca Obtains Exclusive Global License To Develop Antibodies Against COVID-19
MT
04:50aFTSE 100 lags European peers on strong pound
RE
02:23aRQ Biotechnology Ltd Signs Licensing Agreement with AstraZeneca PLC
CI
05/16AstraZeneca Expands License Deal With Drug Discovery Startup to Develop Cancer Therapie..
MT
05/16AstraZeneca Expands Oncology Collaboration With Proteros
MT
05/16Proteros Expands Oncology Collaboration and License Agreement with AstraZeneca
CI
05/16FTSE 100 rises as healthcare, resource-linked gains offset China jitters
RE
05/16NetScientific Shares Rise on Successful Completion of AstraZeneca Covid-19 Antibody Tes..
DJ
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2022 43 739 M - -
Net income 2022 5 294 M - -
Net Debt 2022 22 519 M - -
P/E ratio 2022 37,6x
Yield 2022 2,30%
Capitalization 199 B 199 B -
EV / Sales 2022 5,07x
EV / Sales 2023 4,64x
Nbr of Employees 83 100
Free-Float 96,4%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 128,18 $
Average target price 143,07 $
Spread / Average Target 11,6%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC20.60%198 605
JOHNSON & JOHNSON4.10%468 600
PFIZER, INC.-14.19%284 304
ABBVIE INC.14.82%274 733
ELI LILLY AND COMPANY8.38%269 490
ROCHE HOLDING AG-14.96%260 807